Analysis Tools|
Allele Symbol Allele Name Allele ID |
Cmtm6tm1c(EUCOMM)Wtsi targeted mutation 1c, Wellcome Trust Sanger Institute MGI:6511038 |
||||||||||||||||
| Summary |
3 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased diameter of sciatic nerve axons 2 and 6 months after treatment with tamoxifen at age 2 months
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• normal internode length and nodal and paranodal dimensions
• normal neurofilament density and phosphorylation
|
|
• increased diameter of phrenic and ventral tail nerve axons
• increased diameter of non-myelinated sciatic nerve axons in Remak bundles at ages P9 and 2 months
• normal myelin sheath thickness to axon diameter ratio for phrenic and ventral tail nerve axons
• normal number of axons per Remak bundle, with no axon diameters larger than 1 micrometer
• normal frequency of developmentally sorted promyelinated axons
|
|
• increased sensory nerve action potential (SNAP)
|
|
• increased sensory nerve conduction velocity (SNCV)
|
|
• increased slipping when walking over a regular grid
|
|
• accelerated reaction in hot plate test
|
|
• absence of spontaneous apnea
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
|
|
|
||
